Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e6d4d7321e22e3b85d537f2b3f9b1f9b |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S435-81 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-552 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-0233 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-29 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-5091 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56911 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-50 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-02 |
filingDate |
2008-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38745dab5bea54841caacf53d0f6f0e6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85f102c107cba5c1346113db8dbde9ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b1231eb0414499e43bfcb2ead5016e6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7bdd84d54519a9420c23fbf9deca8781 |
publicationDate |
2016-01-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-20160003306-A |
titleOfInvention |
Ehrlichia canis diva (differentiate infection from vaccinated animals) |
abstract |
The present invention provides an Ehrlichia canis antigen that can be used to detect an animal infected with Erichia canis irrespective of whether it has been vaccinated against Erichia canis. The present invention also provides compositions and methods for determining the presence of erythrocanosin antigens and antibodies. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20200008486-A |
priorityDate |
2007-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |